FDA Clears ORTHO™ Sera ID-MTS for Use on the ORTHO VISION® Analyzer
- Friday, October 18, 2019, 7:03
- Finance
- Add a comment
RARITAN, N.J., Oct. 18, 2019 /PRNewswire/ — Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been cleared by the U.S. Food and Drug Administration for use on the ORTHO VISION® Analyzer….
About the Author
adminasapcorp has written 41802 stories on this site.